https://www.cancer.gov/PublishedContent/RSS/syndication/rss/ncictresults.rss The latest NCI summaries of recently announced results from cancer clinical trials. en-us A drug used for treating breast cancer, known as exemestane, is more effective than a common breast cancer prevention drug, tamoxifen, in preventing breast cancer recurrence in young women who also receive post-surgical treatment to suppress ovarian function. The combined results of the Tamoxifen and Exemestane Trial and Suppression of Ovarian Function Trial were presented at the 2014 ASCO Annual Meeting in Chicago.

]]> 2014-06-01 00:00:00.0